The Journal of Allergy and Clinical Immunology
Volume 114, Issue 6 , Pages 1353-1358 , December 2004

Urinary eicosanoid and tyrosine derivative concentrations in patients with vasculitides

  • Noritaka Higashi, MD, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • Third Department of Internal Medicine, Kagoshima University School of Medicine, Sakuragaoka, Kagoshima
    • Corresponding Author InformationReprint requests: Noritaka Higashi, MD, Scheeles väg1, PO Box 287, National Institute of Environmental Medicine, Karolinska Institutet, SE-171 77 Stockholm, Sweden.
    • ,
  • Haruhisa Mita, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • ,
  • Masami Taniguchi, MD, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • ,
  • Naomi Turikisawa, MD, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • ,
  • Ai Higashi, MD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • Third Department of Internal Medicine, Kagoshima University School of Medicine, Sakuragaoka, Kagoshima
    • ,
  • Yoshinori Ozawa, MD, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • ,
  • Shigeto Tohma, MD, PhD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa
    • ,
  • Kimiyoshi Arimura, MD, PhD

      Affiliations

    • Third Department of Internal Medicine, Kagoshima University School of Medicine, Sakuragaoka, Kagoshima
    • ,
  • Kazuo Akiyama, MD

      Affiliations

    • From the Clinical Research Center, National Sagamihara Hospital, Sagamihara, Kanagawa

Received 23 April 2004 ,Revised 3 August 2004 ,Accepted 20 September 2004.

  • Image Result

    Urinary LTE4 (A) and EDN (B) concentrations in each group. Urinary concentrations are expressed by using the log scale. Patients with CSS, VD, and RA and HC subjects are denoted by closed squares, clo

    Urinary LTE4 (A) and EDN (B) concentrations in each group. Urinary concentrations are expressed by using the log scale. Patients with CSS, VD, and RA and HC subjects are denoted by closed squares, closed triangles, open triangles, and open circles, respectively. Horizontal bars indicate medians. ∗P < .05; †P < .01.

  • Image Result
    Urinary BrY (A) and ClY (B) concentrations in each group. Results are expressed as in Fig 1. ∗P < .05; †P < .01.

    Urinary BrY (A) and ClY (B) concentrations in each group. Results are expressed as in Fig 1. ∗P < .05; †P < .01.

PII: S0091-6749(04)02482-0

doi: 10.1016/j.jaci.2004.09.027

The Journal of Allergy and Clinical Immunology
Volume 114, Issue 6 , Pages 1353-1358 , December 2004

Article Tools

* Image Usage & Resolution